Clinical value:
Purpose of Cervical Cancer Screening: Focus on Persistent Infection and Cancer Risk
The expression of high-risk HPV E7 oncoprotein is positively correlated with precancerous lesions. At the same time, the results do not rely on the experience of pathologists, and the results are more direct and objective. It fills the gap in the market that does not have specific diagnostic indicators for the period from high-risk HPV infection to cervical cancer. blank.
hrHPV E7 protein antibody reagent is developed based on E7 protein-specific Affibody. It is used to qualitatively detect whether there is high expression of E7 protein in cervical tissue samples or exfoliated cells. When it is expressed in cells, it indicates that persistent hrHPV infection has the risk of leading to precancerous lesions and cervical cancer.
Human papillomavirus (HPV) E7 protein antibody reagent—immunohistochemistry
●Main markers: AFT-002 E7 Affibody
●Sample type: cervical lesion tissue, cervical exfoliated cells
●Detection method: immunohistochemistry
● Specifications: 3ml/bottle, 5ml/bottle, 6ml/bottle
Supporting instruments:
Ly-mz36
Ly-m48
